Monitor for initial trading volume of the resold shares, which could create short-term downward pressure. The lack of capital raise is neutral for the balance sheet, but increased float may improve liquidity for institutional investors.
Price Chart
Executive Summary
Evommune's S-1 registration has become effective, allowing for the resale of 4.49 million shares by existing shareholders. The company will not receive proceeds from this offering, which is a follow-on resale rather than a capital-raising IPO.
Key Facts
- S-1 registration effective as of April 24, 2026
- Registration covers resale of 4.49 million shares by existing investors
- Company will not receive any proceeds from the sale
- Offering is a follow-on resale, not a primary capital-raising event
- Evommune is a clinical-stage biotech with product candidates in Phase 2 trials for inflammatory diseases
Financial Impact
No direct financial impact to Evommune — no proceeds from resale
Risk Factors
- Potential near-term share price pressure from shareholder selling post-effectiveness
- No use of proceeds for R&D or operations, limiting near-term strategic flexibility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001330 |
| Document: 9999999995-26-001330-index.html | 9999999995-26-001330 |
| Document: 9999999995-26-001330.txt | 9999999995-26-001330 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $7.21 | awaiting T+60 | — | $5.16 (−28.43%) |
Sep 15, 2026 6w ago | 8-K | $9.99 | awaiting T+60 | — | $5.16 (−48.35%) |
Jul 30, 2026 12w ago | 8-K | $11.35 $5.10 | ▼ −55.07% | ▼ −57.53% | $5.16 (−54.54%) |
Jul 10, 2026 15w ago | Insider Cluster | $12.10 $6.61 | ▼ −45.37% | ▼ −49.37% | $5.16 (−57.36%) |
Jun 29, 2026 17w ago | 8-K | $15.05 $9.60 | ▲ +36.21% | ▲ +40.60% | $5.16 (+65.71%) |
Jun 24, 2026 17w ago | Insider Cluster | $24.13 $9.65 | ▼ −60.01% | ▼ −63.74% | $5.16 (−78.62%) |
Jun 3, 2026 20w ago | Insider Cluster | $20.69 $13.23 | ▲ +36.06% | ▲ +37.94% | $5.16 (+75.06%) |
Jun 2, 2026 21w ago | 144 | $19.73 $13.48 | ▼ −31.68% | ▼ −34.18% | $5.16 (−73.85%) |
Jun 1, 2026 21w ago | Insider Cluster | $19.82 $14.11 | ▼ −28.81% | ▼ −29.93% | $5.16 (−73.97%) |
May 28, 2026 21w ago | 144 | $23.23 $13.67 | ▲ +41.15% | ▲ +42.34% | $5.16 (+77.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers